Objective: The objective of this study was to determine if intractable pain from erythromelalgia could be successfully treated with intrathecal hydromorphone and clonidine. Design: A single case of pain from erythromelalgia refractory to multiple treatment modalities was examined and treated. Setting: The setting is an outpatient pain clinic at a major university teaching hospital. Patient: Our patient is an 82-year-old woman with hypertension and peripheral vascular disease. Intervention: Intrathecal opioid and an α2-agonist were administered. Outcome Measures: Outcome was determined by means of patient self-report during office follow-up visits. Results and Conclusions: Administration of intrathecal opioid and an α2-agonist can be effective in the treatment of the pain of erythromelalgia and offers an alternative pain treatment modality for patients with unremitting pain refractory to more conservative therapy.
- Intrathecal opioids
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
- Clinical Neurology